The aim of our research group "Molecular Oncology" is to elucidate the basic principles restricting cell death in cancer and their relevance for clinical translation. We study the regulation of cell death in healthy and malignant cells. The focus of our work is the understanding of cell death mechanisms and their regulation in tumor cell initiation, tumor maintenance and resistance mechanisms. As model systems we employ genetic deletion or pharmacologic inhibition of individual cell death regulating proteins in various murine tumor models. In addition, we also employ spatiotemporal deletion of individual cell death regulating proteins for characterization of their role in tumor initiation and maintenance. Moreover, we place a specific focus on the rapid translation of murine data into patients. To accomplish this goal, we utilize a broad array of techniques from molecular biology, cell biology, mouse genetics and biochemistry in combination with a strong medical background. Our research covers a broad field of oncological disciplines, ranging from various hematological diseases over to different kinds of lung cancer. Due to the close interaction between scientists and clinicians we can realize translational cancer research in our daily work.

Curriculum vitae

Publications

Grants